Inventor · disambiguated record
Arvia E. Morris
Also filed as: MORRIS ARVIA E · MORRIS ARVIA ELEANOR
23 granted patents·10 pending applications·491 citations·filing 1995–2023
96Inventor score
Top patents by PatentIndex Score
33 records- 0196US6413744B1Methods and host cells for improved cell cultureIMMUNEX CORP·Filed 2000·Granted Jul 2, 2002·88 cites·40 claims
- 0294US5962406ARecombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the sameIMMUNEX CORP·Filed 1995·Granted Oct 5, 1999·96 cites·71 claims
- 0393US11634476B2Mammalian cell cultureAMGEN INC·Filed 2020·Granted Apr 25, 2023·2 cites·41 claims
- 0492US8679487B2Anti-interleukin-4 receptor antibodiesARMITAGE RICHARD J·Filed 2010·Granted Mar 25, 2014·35 cites·17 claims
- 0591US6410711B1DNA encoding CD40 ligand, a cytokine that binds CD40IMMUNEX CORP·Filed 1999·Granted Jun 25, 2002·64 cites·68 claims
- 0690US6309841B1Expression augmenting sequence elements (ease) for eukaryotic expression systemsIMMUNEX CORP·Filed 2000·Granted Oct 30, 2001·25 cites·20 claims
- 0788US11292829B2Mammalian cell cultureFOLLSTAD BRIAN D·Filed 2012·Granted Apr 5, 2022·9 cites·41 claims
- 0888US8053236B2Feed mediaAMGEN INC·Filed 2008·Granted Nov 8, 2011·17 cites·36 claims
- 0988US5981724ADNA encoding CD40 ligand, a cytokine that binds CD40IMMUNEX CORP·Filed 1995·Granted Nov 9, 1999·65 cites·188 claims
- 1086US11827692B2Mammalian cell cultureAMGEN INC·Filed 2023·Granted Nov 28, 2023·0 cites·27 claims
- 1186US7166445B2Methods and host cells for improved cell cultureIMMUNEX CORP·Filed 2005·Granted Jan 23, 2007·5 cites·17 claims
- 1285US11685772B2Mammalian cell cultureAMGEN INC·Filed 2022·Granted Jun 27, 2023·0 cites·30 claims
- 1385US6897040B2Methods and host cells for improved cell cultureIMMUNEX CORP·Filed 2002·Granted May 24, 2005·10 cites·32 claims
- 1484US2023129523A1Mammalian cell cultureAMGEN INC·Filed 2022·Application pending·0 cites
- 1582US6596514B2Expression augmenting sequence elements (EASE) for eukaryotic expression systemsIMMUNEX CORP·Filed 2001·Granted Jul 22, 2003·9 cites·16 claims
- 1681US9587026B2Anti-interleukin-4 receptor antibodiesIMMUNEX CORP·Filed 2014·Granted Mar 7, 2017·3 cites·18 claims
- 1780US2022185869A1Mammalian cell cultureAMGEN INC·Filed 2022·Application pending·0 cites
- 1876US6027915AExpression augmenting sequence elements (EASE) for eukaryotic expression systemsIMMUNEX CORP·Filed 1997·Granted Feb 22, 2000·32 cites·21 claims
- 1975US11673941B2Mammalian cell cultureAMGEN INC·Filed 2020·Granted Jun 13, 2023·0 cites·36 claims
- 2073US7091004B1Regulation of translation for recombinant protein productionIMMUNEX CORP·Filed 2002·Granted Aug 15, 2006·3 cites·14 claims
- 2173US6312951B1Expression augmenting sequence elements (ease) for eukaryotic expression systemsIMMUNEX CORP·Filed 1999·Granted Nov 6, 2001·25 cites·11 claims
- 2271US9388447B2Method for culturing mammalian cells to improve recombinant protein productionAMGEN INC·Filed 2015·Granted Jul 12, 2016·1 cites·11 claims
- 2368US2020080049A1Feed mediaAMGEN INC·Filed 2019·Application pending·0 cites
- 2466US9228168B2Feed mediaMORRIS ARVIA ELEANOR·Filed 2011·Granted Jan 5, 2016·1 cites·34 claims
- 2566US2019023798A1Use of interleukin-4 antagonists and compositions thereofIMMUNEX CORP·Filed 2018·Application pending·0 cites
- 2665US9133493B2Method for culturing mammalian cells to improve recombinant protein productionJERUMS MATTHEW I·Filed 2012·Granted Sep 15, 2015·1 cites·18 claims
- 2764US2018171016A1Use of interleukin-4 antagonists and compositions thereofIMMUNEX CORP·Filed 2018·Application pending·0 cites
- 2861US2017137526A1Use of interleukin-4 antagonists and compositions thereofIMMUNEX CORP·Filed 2017·Application pending·0 cites
- 2961US2017369837A1Feed mediaAMGEN INC·Filed 2017·Application pending·0 cites
- 3057US2016060591A1Feed mediaAMGEN INC·Filed 2015·Application pending·0 cites
- 3153US2007212301A1Monkey Immunoglobulin SequencesAMGEN INC·Filed 2004·Application pending·0 cites
- 3251US2010221823A1Method for culturing mammalian cells to improve recombinant protein productionAMGEN INC·Filed 2008·Application pending·0 cites
- 3337US9012178B2Dipeptides to enhance yield and viability from cell culturesKANG SOHYE·Filed 2011·Granted Apr 21, 2015·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Arvia E. Morris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →